![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/18/2915423/0/en/Alkeus-Pharmaceuticals-Announces-Presentation-of-a-TEASE-3-Study-Update-Showing-Progression-Stalled-in-Early-Stage-Stargardt-Disease-Patients-Treated-with-Gildeuretinol.html
https://www.globenewswire.com/news-release/2024/07/02/2907396/0/en/Accomplished-Biotech-Leader-Michel-Dahan-Joins-Alkeus-as-President-and-CEO.html
https://www.globenewswire.com/news-release/2024/05/29/2889929/0/en/Alkeus-Pharmaceuticals-Appoints-Eric-L-Trachtenberg-as-Chief-Legal-Officer.html
https://www.globenewswire.com/news-release/2024/05/08/2877876/0/en/Alkeus-Pharmaceuticals-Announces-Positive-Interim-Results-Demonstrating-No-Signs-of-Disease-Progression-in-Early-Stage-Stargardt-Disease-Patients-Treated-with-Gildeuretinol.html
https://www.globenewswire.com/news-release/2024/05/01/2873309/0/en/Alkeus-Pharmaceuticals-Announces-Presentation-of-Positive-Gildeuretinol-Data-in-Early-Stage-Stargardt-Patients-During-the-ARVO-2024-Annual-Meeting-May-5-9.html
https://www.globenewswire.com//news-release/2024/01/23/2814088/0/en/Alkeus-Pharmaceuticals-Appoints-Seemi-Khan-M-D-Chief-Medical-Officer.html
https://health.economictimes.indiatimes.com/news/pharma/pharma-industry/alkeus-says-its-eye-therapy-halts-progression-of-genetic-disease/106700407
https://www.globenewswire.com//news-release/2023/12/21/2799954/0/en/Alkeus-Pharmaceuticals-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference-on-Jan-10-2024.html
https://www.globenewswire.com//news-release/2023/11/03/2773327/0/en/Alkeus-Pharmaceuticals-Presents-Positive-Gildeuretinol-Trial-Results-at-American-Academy-of-Ophthalmology-Demonstrating-Significant-Slowing-of-Retinal-Atrophic-Lesions-in-Stargardt.html
https://www.globenewswire.com/news-release/2023/06/05/2681747/0/en/Alkeus-Announces-150-Million-Series-B-Financing-Supporting-Rapid-Registration-Path-for-gildeuretinol-ALK-001-in-the-Treatment-of-Stargardt-Disease.html